Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: A Meta-Analysis of Population-Based Studies Involving 17,180 Individuals.

Georgakis MK, Malik R, Björkbacka H, Pana TA, Demissie S, Ayers C, Elhadad MA, Fornage M, Beiser AS, Benjamin EJ, Boekholdt MS, Engström G, Herder C, Hoogeveen RC, Koenig W, Melander O, Orho-Melander M, Schiopu A, Söderholm M, Wareham N, Ballantyne CM, Peters A, Seshadri S, Myint PK, Nilsson J, de Lemos JA, Dichgans M.

Circ Res. 2019 Sep 3. doi: 10.1161/CIRCRESAHA.119.315380. [Epub ahead of print]

PMID:
31476962
2.

Premorbid levels of high-sensitivity cardiac troponin T and natriuretic peptide and prognosis after incident myocardial infarction.

Mok Y, Sang Y, Ballew SH, Hoogeveen RC, Ballantyne CM, Rosamond W, Coresh J, Selvin E, Matsushita K.

Am Heart J. 2019 Jul 13;216:62-73. doi: 10.1016/j.ahj.2019.07.002. [Epub ahead of print]

PMID:
31404723
3.

High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change.

Pokharel Y, Mouhanna F, Schneider ALC, Rawlings AM, Knopman DS, Nambi V, Virani SS, Hoogeveen RC, Alonso A, Heiss G, Coresh J, Mosley T, Gottesman R, Selvin E, Ballantyne C, Power MC.

J Am Geriatr Soc. 2019 Jul 30. doi: 10.1111/jgs.16092. [Epub ahead of print]

PMID:
31359423
4.

Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study).

Madan N, Lee AK, Matsushita K, Hoogeveen RC, Ballantyne CM, Selvin E, McEvoy JW.

Am J Cardiol. 2019 Jul 15;124(2):245-252. doi: 10.1016/j.amjcard.2019.04.030. Epub 2019 Apr 23.

PMID:
31088661
5.

High-sensitivity Cardiac Troponin and Natriuretic Peptide in Persons Without Cardiovascular Disease and Subsequent Risk of Infection: Atherosclerosis Risk in Communities Study.

Ishigami J, Hoogeveen RC, Ballantyne CM, Folsom AR, Coresh J, Selvin E, Matsushita K.

Am J Epidemiol. 2019 May 7. pii: kwz113. doi: 10.1093/aje/kwz113. [Epub ahead of print]

PMID:
31063194
6.

High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.

Jia X, Sun W, Hoogeveen RC, Nambi V, Matsushita K, Folsom AR, Heiss G, Couper DJ, Solomon SD, Boerwinkle E, Shah A, Selvin E, de Lemos JA, Ballantyne CM.

Circulation. 2019 Jun 4;139(23):2642-2653. doi: 10.1161/CIRCULATIONAHA.118.038772. Epub 2019 Apr 29.

PMID:
31030544
7.

Precision of aiming with a portable X-ray device (Nomad Pro 2) compared to a wall-mounted device in intraoral radiography.

Hoogeveen RC, Meertens BR, Berkhout WER.

Dentomaxillofac Radiol. 2019 Jul;48(5):20180221. doi: 10.1259/dmfr.20180221. Epub 2019 May 13.

PMID:
30982345
8.

Cancer Survivorship and Subclinical Myocardial Damage: The Atherosclerosis Risk in Communities (ARIC) Study.

Florido R, Lee AK, McEvoy JW, Hoogeveen RC, Koton S, Vitolins MZ, Shenoy C, Russell SD, Blumenthal RS, Ndumele CE, Ballantyne CM, Joshu CE, Platz EA, Selvin E.

Am J Epidemiol. 2019 Mar 30. pii: kwz088. doi: 10.1093/aje/kwz088. [Epub ahead of print]

PMID:
30927355
9.

NT -pro BNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure.

Whitman IR, Vittinghoff E, DeFilippi CR, Gottdiener JS, Alonso A, Psaty BM, Heckbert SR, Hoogeveen RC, Arking DE, Selvin E, Chen LY, Dewland TA, Marcus GM.

J Am Heart Assoc. 2019 Apr 2;8(7):e010868. doi: 10.1161/JAHA.118.010868.

10.

Central and peripheral pulse wave velocity and subclinical myocardial stress and damage in older adults.

Liu S, Kim ED, Wu A, Meyer ML, Cheng S, Hoogeveen RC, Ballantyne CM, Tanaka H, Heiss G, Selvin E, Matsushita K.

PLoS One. 2019 Feb 27;14(2):e0212892. doi: 10.1371/journal.pone.0212892. eCollection 2019.

11.

Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study.

Saeed A, Sun W, Agarwala A, Virani SS, Nambi V, Coresh J, Selvin E, Boerwinkle E, Jones PH, Ballantyne CM, Hoogeveen RC.

Atherosclerosis. 2019 Mar;282:52-56. doi: 10.1016/j.atherosclerosis.2018.12.022. Epub 2018 Dec 30.

PMID:
30685442
12.

Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection.

Hoogeveen RC, Robidoux MP, Schwarz T, Heydmann L, Cheney JA, Kvistad D, Aneja J, Melgaço JG, Fernandes CA, Chung RT, Boonstra A, Kim AY, Baumert TF, Timm J, Lewis-Ximenez LL, Tonnerre P, Lauer GM.

Gut. 2019 May;68(5):893-904. doi: 10.1136/gutjnl-2018-316644. Epub 2018 Dec 22.

PMID:
30580250
13.

Prospective Study of Endogenous Hormones and Incidence of Venous Thromboembolism: The Atherosclerosis Risk in Communities Study.

Roetker NS, MacLehose RF, Hoogeveen RC, Ballantyne CM, Basu S, Cushman M, Folsom AR.

Thromb Haemost. 2018 Nov;118(11):1940-1950. doi: 10.1055/s-0038-1673613. Epub 2018 Oct 8.

PMID:
30296818
14.

Ambient dose during intra-oral radiography with current techniques: Part 2 quantifying the remnant beam - an in vivo study.

Hoogeveen RC, Pfältzer CC, Berkhout W.

Dentomaxillofac Radiol. 2018 Oct;47(7):20180205. doi: 10.1259/dmfr.20180205. Epub 2018 Sep 5.

PMID:
30182743
15.

Innocent Spectators, Helping Hands or a Fifth Column? Acute Hepatitis A Infection Reveals Important Insights Into Bystander T Cells.

Hoogeveen RC, Lauer GM.

Hepatology. 2019 Mar;69(3):1337-1339. doi: 10.1002/hep.30216. Epub 2019 Feb 5. No abstract available.

PMID:
30102782
16.

Association of N-terminal pro B-type natriuretic peptide (NT-proBNP) change with the risk of atrial fibrillation in the ARIC cohort.

Li L, Selvin E, Lutsey PL, Hoogeveen RC, O'Neal WT, Soliman EZ, Chen LY, Alonso A.

Am Heart J. 2018 Oct;204:119-127. doi: 10.1016/j.ahj.2018.07.008. Epub 2018 Aug 10.

PMID:
30099337
17.

Diagnostic Performance of 1,5-Anhydroglucitol Compared to 2-H Glucose in the Atherosclerosis Risk in Communities Study.

Warren B, Lee AK, Ballantyne CM, Hoogeveen RC, Pankow JS, Grams M, Köttgen A, Selvin E.

Clin Chem. 2018 Oct;64(10):1536-1537. doi: 10.1373/clinchem.2018.291773. Epub 2018 Aug 7. No abstract available.

PMID:
30087139
18.

Ambient dose during intraoral radiography with current techniques: Part 1 conversion factor for scattered radiation using a rectangular collimator.

Hoogeveen RC, de Randamie TI, Soemodihardjo GM, Berkhout W.

Dentomaxillofac Radiol. 2018 Oct;47(7):20180108. doi: 10.1259/dmfr.20180108. Epub 2018 Sep 5.

PMID:
30028183
19.

Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.

Folsom AR, Lutsey PL, Heckbert SR, Poudel K, Basu S, Hoogeveen RC, Cushman M, Ballantyne CM.

J Thromb Haemost. 2018 Oct;16(10):1964-1972. doi: 10.1111/jth.14241. Epub 2018 Aug 11.

PMID:
30007116
20.

Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease.

Saeed A, Feofanova EV, Yu B, Sun W, Virani SS, Nambi V, Coresh J, Guild CS, Boerwinkle E, Ballantyne CM, Hoogeveen RC.

J Am Coll Cardiol. 2018 Jul 10;72(2):156-169. doi: 10.1016/j.jacc.2018.04.050.

21.

The Association of Biomarkers of Inflammation and Extracellular Matrix Degradation With the Risk of Abdominal Aortic Aneurysm: The ARIC Study.

Tang W, Yao L, Hoogeveen RC, Alonso A, Couper DJ, Lutsey PL, Steenson CC, Guan W, Hunter DW, Lederle FA, Folsom AR.

Angiology. 2019 Feb;70(2):130-140. doi: 10.1177/0003319718785278. Epub 2018 Jun 26.

PMID:
29945457
22.

Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.

Ding N, Kwak L, Ballew SH, Jaar B, Hoogeveen RC, Ballantyne CM, Sharrett AR, Folsom AR, Heiss G, Salameh M, Coresh J, Hirsch AT, Selvin E, Matsushita K.

Atherosclerosis. 2018 Jul;274:86-93. doi: 10.1016/j.atherosclerosis.2018.04.042. Epub 2018 Apr 30.

23.

The association of mid-to late-life systemic inflammation with white matter structure in older adults: The Atherosclerosis Risk in Communities Study.

Walker KA, Windham BG, Power MC, Hoogeveen RC, Folsom AR, Ballantyne CM, Knopman DS, Selvin E, Jack CR Jr, Gottesman RF.

Neurobiol Aging. 2018 Aug;68:26-33. doi: 10.1016/j.neurobiolaging.2018.03.031. Epub 2018 Apr 4.

24.

High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Matsushita K, Kwak L, Yang C, Pang Y, Ballew SH, Sang Y, Hoogeveen RC, Jaar BG, Selvin E, Ballantyne CM, Sharrett AR, Folsom AR, Heiss G, Coresh J, Hirsch AT.

Eur Heart J. 2018 Jul 1;39(25):2412-2419. doi: 10.1093/eurheartj/ehy106.

25.

A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women.

White DL, Hoogeveen RC, Chen L, Richardson P, Ravishankar M, Shah P, Tinker L, Rohan T, Whitsel EA, El-Serag HB, Jiao L.

Cancer Med. 2018 May;7(5):2180-2191. doi: 10.1002/cam4.1426. Epub 2018 Mar 23.

26.

Usefulness of Lipoprotein-Associated Phospholipase A2 Activity and C-Reactive Protein in Identifying High-Risk Smokers for Atherosclerotic Cardiovascular Disease (from the Atherosclerosis Risk in Communities Study).

Tibuakuu M, Kianoush S, DeFilippis AP, McEvoy JW, Zhao D, Guallar E, Ballantyne CM, Hoogeveen RC, Blaha MJ, Michos ED.

Am J Cardiol. 2018 May 1;121(9):1056-1064. doi: 10.1016/j.amjcard.2018.01.020. Epub 2018 Feb 6.

27.

Relation of Lifestyle Factors and Life's Simple 7 Score to Temporal Reduction in Troponin Levels Measured by a High-Sensitivity Assay (from the Atherosclerosis Risk in Communities Study).

Fretz A, McEvoy JW, Rebholz CM, Ndumele CE, Florido R, Hoogeveen RC, Ballantyne CM, Selvin E.

Am J Cardiol. 2018 Feb 15;121(4):430-436. doi: 10.1016/j.amjcard.2017.11.017. Epub 2017 Nov 24.

28.

Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study.

Aronis KN, Zhao D, Hoogeveen RC, Alonso A, Ballantyne CM, Guallar E, Jones SR, Martin SS, Nazarian S, Steffen BT, Virani SS, Michos ED.

J Am Heart Assoc. 2017 Dec 15;6(12). pii: e007372. doi: 10.1161/JAHA.117.007372.

29.

Lipoprotein-associated phospholipase A2 and risk of incident peripheral arterial disease: Findings from The Atherosclerosis Risk in Communities study (ARIC).

Garg PK, Norby FL, Polfus LM, Boerwinkle E, Gibbs RA, Grove ML, Folsom AR, Garimella PS, Matsushita K, Hoogeveen RC, Ballantyne CM.

Atherosclerosis. 2018 Jan;268:12-18. doi: 10.1016/j.atherosclerosis.2017.11.007. Epub 2017 Nov 14.

30.

Galectin-3 and Venous Thromboembolism Incidence: the Atherosclerosis Risk in Communities (ARIC) Study.

Fashanu OE, Heckbert SR, Aguilar D, Jensen PN, Ballantyne CM, Basu S, Hoogeveen RC, deFilippi C, Cushman M, Folsom AR.

Res Pract Thromb Haemost. 2017 Oct;1(2):223-230. doi: 10.1002/rth2.12038. Epub 2017 Sep 4.

31.

Midlife Systemic Inflammation, Late-Life White Matter Integrity, and Cerebral Small Vessel Disease: The Atherosclerosis Risk in Communities Study.

Walker KA, Power MC, Hoogeveen RC, Folsom AR, Ballantyne CM, Knopman DS, Windham BG, Selvin E, Jack CR Jr, Gottesman RF.

Stroke. 2017 Dec;48(12):3196-3202. doi: 10.1161/STROKEAHA.117.018675. Epub 2017 Nov 3.

32.

Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study.

Walker KA, Hoogeveen RC, Folsom AR, Ballantyne CM, Knopman DS, Windham BG, Jack CR Jr, Gottesman RF.

Neurology. 2017 Nov 28;89(22):2262-2270. doi: 10.1212/WNL.0000000000004688. Epub 2017 Nov 1.

33.

Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.

Fashanu OE, Norby FL, Aguilar D, Ballantyne CM, Hoogeveen RC, Chen LY, Soliman EZ, Alonso A, Folsom AR.

Am Heart J. 2017 Oct;192:19-25. doi: 10.1016/j.ahj.2017.07.001. Epub 2017 Jul 8.

34.

Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.

Rebholz CM, Selvin E, Liang M, Ballantyne CM, Hoogeveen RC, Aguilar D, McEvoy JW, Grams ME, Coresh J.

Kidney Int. 2018 Jan;93(1):252-259. doi: 10.1016/j.kint.2017.06.028. Epub 2017 Aug 31.

35.

Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study.

van Capelleveen JC, Bochem AE, Boekholdt SM, Mora S, Hoogeveen RC, Ballantyne CM, Ridker PM, Sun W, Barter PJ, Tall AR, Zwinderman AH, Kastelein JJP, Wareham NJ, Khaw KT, Hovingh GK.

J Am Heart Assoc. 2017 Aug 3;6(8). pii: e006636. doi: 10.1161/JAHA.117.006636.

36.

Hepatitis B virus infection and the immune response: The big questions.

Boeijen LL, Hoogeveen RC, Boonstra A, Lauer GM.

Best Pract Res Clin Gastroenterol. 2017 Jun;31(3):265-272. doi: 10.1016/j.bpg.2017.05.003. Epub 2017 May 22. Review.

PMID:
28774408
37.

Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.

Puri R, Ballantyne CM, Hoogeveen RC, Shao M, Barter P, Libby P, Chapman MJ, Erbel R, Arsenault BJ, Raichlen JS, Nissen SE, Nicholls SJ.

Atherosclerosis. 2017 Aug;263:137-144. doi: 10.1016/j.atherosclerosis.2017.06.026. Epub 2017 Jun 15.

PMID:
28641153
38.

The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.

Agarwala A, Pokharel Y, Saeed A, Sun W, Virani SS, Nambi V, Ndumele C, Shahar E, Heiss G, Boerwinkle E, Konety S, Hoogeveen RC, Ballantyne CM.

Atherosclerosis. 2017 Jul;262:131-137. doi: 10.1016/j.atherosclerosis.2017.05.014. Epub 2017 May 12.

39.

Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study.

Arenas de Larriva AP, Norby FL, Chen LY, Soliman EZ, Hoogeveen RC, Arking DE, Loehr LR, Alonso A.

Int J Cardiol. 2017 Aug 15;241:223-228. doi: 10.1016/j.ijcard.2017.04.005. Epub 2017 Apr 6.

40.

Detection of genetic loci associated with plasma fetuin-A: a meta-analysis of genome-wide association studies from the CHARGE Consortium.

Jensen MK, Jensen RA, Mukamal KJ, Guo X, Yao J, Sun Q, Cornelis M, Liu Y, Chen MH, Kizer JR, Djoussé L, Siscovick DS, Psaty BM, Zmuda JM, Rotter JI, Garcia M, Harris T, Chen I, Goodarzi MO, Nalls MA, Keller M, Arnold AM, Newman AB, Hoogeveen RC, Rexrode KM, Rimm EB, Hu FB, Ramachandran VS, Katz R, Pankow JS, Ix JH.

Hum Mol Genet. 2017 Jun 1;26(11):2156-2163. doi: 10.1093/hmg/ddx091.

41.

Postprandial lipemia and the risk of coronary heart disease and stroke: the Atherosclerosis Risk in Communities (ARIC) Study.

Kats D, Sharrett AR, Ginsberg HN, Nambi V, Ballantyne CM, Hoogeveen RC, Heiss G.

BMJ Open Diabetes Res Care. 2017 Feb 1;5(1):e000335. doi: 10.1136/bmjdrc-2016-000335. eCollection 2017.

42.

Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study.

Pokharel Y, Sun W, Virani SS, Nambi V, Hoogeveen RC, Chang PP, Ndumele CE, Solomon SD, Bozkurt B, Selvin E, Ballantyne CM, Deswal A.

JACC Heart Fail. 2017 Jan;5(1):56-63. doi: 10.1016/j.jchf.2016.10.010. Epub 2016 Dec 21.

43.

Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study.

Pokharel Y, Sun W, Villareal DT, Selvin E, Virani SS, Ndumele CE, Hoogeveen RC, Coresh J, Boerwinkle E, Butler KR, Solomon SD, Pankow JS, Bozkurt B, Ballantyne CM, Nambi V.

Eur J Prev Cardiol. 2017 Apr;24(6):628-638. doi: 10.1177/2047487316683071. Epub 2016 Dec 12.

44.

Postprandial Monocyte Activation in Individuals With Metabolic Syndrome.

Khan IM, Pokharel Y, Dadu RT, Lewis DE, Hoogeveen RC, Wu H, Ballantyne CM.

J Clin Endocrinol Metab. 2016 Nov;101(11):4195-4204. Epub 2016 Aug 30.

45.

Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study.

Agarwala A, Virani S, Couper D, Chambless L, Boerwinkle E, Astor BC, Hoogeveen RC, Coresh J, Sharrett AR, Folsom AR, Mosley T, Ballantyne CM, Nambi V.

Atherosclerosis. 2016 Oct;253:156-163. doi: 10.1016/j.atherosclerosis.2016.08.028. Epub 2016 Aug 25.

46.

Severe Hypoglycemia and Elevated High-Sensitivity Cardiac Troponin T in Older Adults With Diabetes: The ARIC Study.

Lee AK, McEvoy JW, Hoogeveen RC, Ballantyne CM, Selvin E.

J Am Coll Cardiol. 2016 Sep 20;68(12):1370-1. doi: 10.1016/j.jacc.2016.06.049. No abstract available.

47.

Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control.

McEvoy JW, Chen Y, Rawlings A, Hoogeveen RC, Ballantyne CM, Blumenthal RS, Coresh J, Selvin E.

J Am Coll Cardiol. 2016 Oct 18;68(16):1713-1722. doi: 10.1016/j.jacc.2016.07.754. Epub 2016 Aug 30.

48.

A genetic risk score is associated with statin-induced low-density lipoprotein cholesterol lowering.

Leusink M, Maitland-van der Zee AH, Ding B, Drenos F, van Iperen EP, Warren HR, Caulfield MJ, Cupples LA, Cushman M, Hingorani AD, Hoogeveen RC, Hovingh GK, Kumari M, Lange LA, Munroe PB, Nyberg F, Schreiner PJ, Sivapalaratnam S, de Bakker PI, de Boer A, Keating BJ, Asselbergs FW, Onland-Moret NC.

Pharmacogenomics. 2016 Apr;17(6):583-91. doi: 10.2217/pgs.16.8. Epub 2016 Apr 5.

49.

The value of thyroid shielding in intraoral radiography.

Hoogeveen RC, Hazenoot B, Sanderink GC, Berkhout WE.

Dentomaxillofac Radiol. 2016;45(5):20150407. doi: 10.1259/dmfr.20150407. Epub 2016 Mar 23.

50.

Plasma Levels of Endothelial Microparticles Bearing Monomeric C-reactive Protein are Increased in Peripheral Artery Disease.

Crawford JR, Trial J, Nambi V, Hoogeveen RC, Taffet GE, Entman ML.

J Cardiovasc Transl Res. 2016 Jun;9(3):184-93. doi: 10.1007/s12265-016-9678-0. Epub 2016 Feb 18.

Supplemental Content

Loading ...
Support Center